ATRenew Inc
NYSE:RERE
ATRenew Inc
Research & Development
ATRenew Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
ATRenew Inc
NYSE:RERE
|
Research & Development
-¥193.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Research & Development
-¥52.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-26%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Research & Development
-¥11B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Research & Development
-¥1.2B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Research & Development
-¥20.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Research & Development
-¥16B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-32%
|
See Also
What is ATRenew Inc's Research & Development?
Research & Development
-193.8m
CNY
Based on the financial report for Dec 31, 2023, ATRenew Inc's Research & Development amounts to -193.8m CNY.
What is ATRenew Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-24%
Over the last year, the Research & Development growth was 15%. The average annual Research & Development growth rates for ATRenew Inc have been -9% over the past three years , -24% over the past five years .